{"id":"W2060632341","doi":"10.1016/j.bbmt.2013.08.002","title":"Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; IC Design Education Center; Astellas Pharma; Eisai; Genentech; CellGenix; Therakos; Sigma-Tau Pharmaceuticals; Medical College of Wisconsin; StemCyte; BioMarin Pharmaceutical; U.S. Navy; Celgene; Osiris Therapeutics; WellPoint; HistoGenetics; Teva Pharmaceutical Industries; Otsuka America; Pfizer; Biogen; AABB; U.S. Department of Defense; Sanofi; Amgen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Multiple myeloma; Lenalidomide; Cohort; Thalidomide; Bortezomib; Internal medicine; Transplantation; Multivariate analysis; Autologous stem-cell transplantation; Hematopoietic stem cell transplantation; Oncology; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008206506,0.0001043203,0.0002739112,0.0002513873,0.00002710596,0.00000361892,0.0000241793,0.0001159919,0.00002109486],"category_scores_gemma":[0.0000168565,0.0000800674,0.00004253222,0.00008556049,0.00010275,0.00008073834,0.000001744233,0.0000398818,4.83634e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003378873,"about_ca_system_score_gemma":0.00001796083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007423557,"about_ca_topic_score_gemma":0.0001624682,"domain_scores_codex":[0.9993242,0.00004813194,0.0002501454,0.0001739092,0.00006377699,0.0001398537],"domain_scores_gemma":[0.9995766,0.000179325,0.00007235579,0.00005987207,0.00005962713,0.00005218856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001169,0.0001736399,0.7156196,0.0002158197,0.0001230268,0.000004824842,0.0008858565,3.496614e-7,0.164553,0.0001567581,0.000001169774,0.1170969],"study_design_scores_gemma":[0.009989788,0.001369532,0.9129354,0.00004054314,0.0001173177,0.00003550529,0.00004167437,0.0001466067,0.07500669,0.0002508641,0.000006757321,0.00005930987],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980862,0.0006231182,0.0002596873,0.000192957,0.00002096832,0.0006102189,0.0001087403,0.00001258184,0.00008559229],"genre_scores_gemma":[0.9942128,0.003949405,0.001097673,0.0000234443,0.00000654851,0.00009201968,0.0005712071,0.000007781353,0.00003912941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1973158,"threshold_uncertainty_score":0.3265054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03081379634762552,"score_gpt":0.3165390970510847,"score_spread":0.2857253007034592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}